This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Michael Yu
Partner at Cooley LLP


Mr. Michael Yu’s practice focuses on initial public offerings and other equity capital markets transactions on the Hong Kong Stock Exchange, pre-IPO investments, public takeovers and listing rules and securities regulations compliance.

Michael has actively participated in the strategic initiative by the Hong Kong Stock Exchange to attract new-economy companies to list in Hong Kong. In particular, he advised Ascletis Pharma on its $400 million Hong Kong IPO in 2018, the first pre-revenue biotech IPO on the HKEX under its new listing regime for companies from emerging and innovative sectors. He has also advised a number of new-economy companies, including companies in biotech and internet sectors, on their Hong Kong IPOs.

Michael received his LLM from New York University School of Law and Peking University Law School. He was recognized in IFLR1000 2019 and 2020 as a Notable Practitioner for equity capital markets work.

Agenda Sessions

  • Key IPO considerations for life sciences companies


Speakers at this event